Basic info
Industry
biotechnology research
Sectors
autoimmune diseases
Biotechnology
Immunotherapy
allergy
covid-19
Pharmaceutical
food allergy
celiac diseases
ARDS
Date founded
2016
Funding rounds raised
Total raised
$83K
from 2 investors over 2 rounds
A
Allero Therapeutics raised undisclosed on April 17, 2019
Investors: Swanbridge Capital
A
Allero Therapeutics raised $83K on September 1, 2018
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)